|
|
发表于 9-10-2020 07:13 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Mar 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2020 | 31 Mar 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 35,560 | 40,750 | 89,868 | 147,139 | | 2 | Profit/(loss) before tax | -2,823 | -899 | 108 | 722 | | 3 | Profit/(loss) for the period | -3,842 | -467 | -1,004 | 283 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -3,490 | -576 | -359 | 335 | | 5 | Basic earnings/(loss) per share (Subunit) | -1.21 | -0.20 | -0.12 | 0.12 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2700 | 0.2800
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 5-11-2020 01:02 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-12-2020 08:45 AM
|
显示全部楼层
本帖最后由 icy97 于 19-1-2021 04:33 AM 编辑
Type | Announcement | Subject | MEMORANDUM OF UNDERSTANDING | Description | Bintai Kinden Corporation Berhad (BKCB or Company)- Memorandum of Understanding between BKCB and Nugenerex Immuno-Oncology on New Business Opportunity (COVID-19 Vaccine) | The Board of Directors of BKCB wishes to announce that Bintai Kinden Corporation Berhad (“BKCB”) has on 14 August 2020 entered into a Memorandum of Understanding (“MOU”) with Nugenerex Immuno-Oncology, a company incorporated in the United States of America (“GENEREX”) for establishing the preliminary understanding arrangement for the collaboration in funding, launching and management of the synthetic peptide vaccine for SARS-CoV-2 (“Vaccine”) [collectively the “Project”] subject to the terms and conditions of the MOU.
Please refer to the attachment for further details.
This announcement is dated 17 August 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3078035
Type | Announcement | Subject | OTHERS | Description | BINTAI KINDEN CORPORATION BERHAD- HEADS OF AGREEMENT WITH GENEREX BIOTECHNOLOGY CORPORATION AND NUGENEREX IMMUNO-ONCOLOGY INC. | [For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 17 August 2020 in relation to the Memorandum of Understanding between the Company and NuGenerex Immuno-Oncology]
We refer to the announcements made on 17 August 2020 and 19 August 2020 in relation to the Memorandum of Understanding (“MOU”) entered into between the Company and NuGenerex Immuno-Oncology Inc.
For details of this announcement, please refer to the attachment.
This announcement is dated 21 September 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3089395
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-12-2020 09:56 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 26-12-2020 07:45 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Jun 2020 | 30 Jun 2019 | 30 Jun 2020 | 30 Jun 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 13,689 | 13,600 | 13,689 | 13,600 | | 2 | Profit/(loss) before tax | -1,463 | 11,103 | -1,463 | 11,103 | | 3 | Profit/(loss) for the period | -1,463 | 11,103 | -1,463 | 11,103 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,309 | 11,224 | -1,309 | 11,224 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.70 | 3.90 | -0.70 | 3.90 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.4000 | 0.2600
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 9-1-2021 04:58 AM
|
显示全部楼层
本帖最后由 icy97 于 12-1-2021 06:03 AM 编辑
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | PROPOSED PRIVATE PLACEMENT | On behalf of the Board of Directors of Bintai Kinden Corporation Berhad (“BKCB” or “Company”), KAF Investment Bank Berhad wishes to announce that the Company is proposing to undertake the proposed private placement of up to 10% of the issued share capital in BKCB in accordance with the general mandate pursuant to Sections 75 and 76 of the Companies Act 2016 ("Proposed Private Placement").
Kindly refer to the attached document for the full announcement on the Proposed Private Placement.
This announcement is dated 4 September 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3085737
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | PROPOSED PRIVATE PLACEMENT | (For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcement dated 4 September 2020 in relation to the Proposed Private Placement.)
We refer to the announcement made on 4 September 2020 and 7 September 2020 in relation to the Proposed Private Placement.
On behalf of the Board, KAF IB wishes to announce additional information in relation to the Proposed Private Placement. Further details are set out in the attachment below.
This announcement is dated 9 September 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3086969
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-1-2021 06:51 AM
|
显示全部楼层
| BINTAI KINDEN CORPORATION BERHAD |
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-22092020-00001 | Subject | Bintai Kinden Corporation Berhad ("BKCB" or "Company") | Description | Heads of Agreement between BKCB and Generex Biotechnology Corporation and NuGenerex Immuno-Oncology, Inc. (collectively referred to as "Generex") | Query Letter Contents | We refer to your Company’s announcement dated 21 September 2020 in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
1) To state the current stage of development and clinical trials of the Covid-19 Vaccine and whether necessary approvals have been obtained from the relevant government/authorities. If yes, to provide the name thereof.
2) To elaborate further on how the Company intends to conduct the independent research and further research, the estimated capital outlay, the required medical expertise and research facilities, and the required government's/authorities' approvals.
3) To state the purpose of the payment of USD2 million, source of funds and the expected date of payment.
| Please refer to the attachment for details of this announcement.
This announcement is dated 23 September 2020. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 24-1-2021 08:56 AM
|
显示全部楼层
| BINTAI KINDEN CORPORATION BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Private placement of 28,700,000 new ordinary shares in Bintai Kinden Corporation Berhad representing approximately 10% of the total number of issued shares of the Company | No. of shares issued under this corporate proposal | 28,700,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.5200 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 318,291,740 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 74,435,042.000 | Listing Date | 28 Sep 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-1-2021 07:25 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 28-1-2021 09:07 AM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-28092020-00001 | Subject | BINTAI KINDEN CORPORATION BERHAD ("BKCB" or "Company") | Description | Memorandum of Understanding with Institut Jantung Negara Sdn Bhd ("IJNSB") | Query Letter Contents | We refer to your Company’s announcement dated 28 September 2020 in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
1) To clarify what are the 3 stages as stated in Section 3.1(i) of the announcement.
2) To state the estimated commencement of the clinical test by IJNSB.
3) Further elaboration on the roles and responsibilities of IJNSB, estimated payment/contribution from BKCB to IJNSB, and expected returns/benefits to be derived by IJNSB pursuant to the Cooperation.
4) To state the rationale for the length of the MOU of 3 years.
5) To state the estimated cost and expenses to be incurred by BINTAI pursuant to the Cooperation.
6) To explain further on the estimated gross development value of the Proposed Development. | For details of this announcement, please refer to the attachment.
This announcement is dated 29 September 2020. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 24-2-2021 08:52 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 1-3-2021 09:01 AM
|
显示全部楼层
| BINTAI KINDEN CORPORATION BERHAD |
Date of change | 12 Oct 2020 | Name | MR KU CHONG HONG | Age | 32 | Gender | Male | Nationality | Malaysia | Type of change | Appointment | Designation | Chief Financial Officer |
Qualifications| No | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Degree | Bachelor of Accounting (Hons) anda member of the Malaysian Institute of Accountants. | Multimedia University | |
| | | Working experience and occupation | Mr Ku Chong Hong began his career in auditing with several audit firms before joining Grant Thornton Malaysia as an Audit Senior Manager in 2017. Throughout his career as an auditor for more than 8 years, he had gained vast exposure in audit and assurance, and business advisory related fields through his portfolios of various local and international companies involved in a broad spectrum of industries such as property development, construction, manufacturing, trading, poultry, agriculture, aquaculture, service provider, trading of software and real estate. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 9-3-2021 07:54 AM
|
显示全部楼层
本帖最后由 icy97 于 15-3-2021 07:32 AM 编辑
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | BINTAI KINDEN CORPORATION BERHAD ("BKCB" OR "COMPANY") PROPOSED PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED ORDINARY SHARES IN BKCB | On behalf of the Board of Directors of BKCB, M&A Securities Sdn Bhd wishes to announce that the Company proposes to undertake a private placement of up to 10% of the issued ordinary shares in BKCB (“Proposed Private Placement”).
Further information on the Proposed Private Placement is disclosed in the attachment herein.
This announcement is dated 16 October 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097268
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | BINTAI KINDEN CORPORATION BERHAD ("BKCB" OR "COMPANY")PROPOSED PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED ORDINARY SHARES IN BKCB | Unless otherwise defined, the definitions set out in the announcement in relation to the Proposed Private Placement dated 16 October 2020 (“Announcement”) shall apply herein.
Further to the Announcement, on behalf of the Board, M&A Securities wishes to announce further information in relation to the Proposed Private Placement as set out in the attachment below.
This announcement is dated 22 October 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3098756
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-3-2021 09:13 AM
|
显示全部楼层
本帖最后由 icy97 于 16-8-2021 07:45 AM 编辑
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
OTHER ISSUE OF SECURITIES | Description | PROPOSED DEBT SETTLEMENT | On behalf of the Board of Directors of Bintai Kinden Corporation Berhad (“BKCB” or “Company”), KAF Investment Bank Berhad wishes to announce that the Company is proposing to undertake a proposed settlement of the amount owing by Optimal Property Management Sdn Bhd, a wholly-owned subsidiary of BKCB to Handal Jayabina Sdn Bhd of approximately RM23.4 million (“Proposed Debt Settlement”).
Kindly refer to the attached document for the full announcement on the Proposed Debt Settlement.
This announcement is dated 21 October 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3098243
| BINTAI KINDEN CORPORATION BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | PRIVATE PLACEMENT OF UP TO 10% OF THE ISSUED ORDINARY SHARES IN BINTAI KINDEN CORPORATION BERHAD | No. of shares issued under this corporate proposal | 31,800,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.5650 | Par Value($$) (if applicable) | Malaysian Ringgit (MYR) 0.000 | | Latest issued share capital after the above corporate proposal in the following | Units | 350,091,740 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 90,146,887.000 | Listing Date | 12 Nov 2020 |
Type | Announcement | Subject | MEMORANDUM OF UNDERSTANDING | Description | Bintai Kinden Corporation Berhad (BKCB or Company)- Memorandum of Understanding between Bintai Healthcare Sdn Bhd and IEC Properties Pty. Ltd | For details of this announcement, please refer to the attachment.
This announcement is dated 12 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3104383
Type | Announcement | Subject | MEMORANDUM OF UNDERSTANDING | Description | Bintai Kinden Corporation Berhad- Memorandum of Understanding between Bintai Healthcare Sdn Bhd and Generex Biotechnology Corporation (Generex) and NuGenerex Immuno-Oncology (NuGenerex) | For details of this announcement, please refer to the attachment.
This announcement is dated 25 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3107745
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2020 | 30 Sep 2019 | 30 Sep 2020 | 30 Sep 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 12,278 | 16,388 | 25,967 | 29,988 | | 2 | Profit/(loss) before tax | -2,999 | -3,448 | -4,462 | 7,655 | | 3 | Profit/(loss) for the period | -2,999 | -3,448 | -4,462 | 7,655 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -2,849 | -3,362 | -4,158 | 7,862 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.90 | -1.17 | -1.31 | 2.73 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.2700 | 0.2600
|
| BINTAI KINDEN CORPORATION BERHAD |
Date of change | 16 Dec 2020 | Name | MR YEN YEW WING @ YEN YEW MING | Age | 67 | Gender | Male | Nationality | Malaysia | Designation | Executive Director | Directorate | Executive | Type of change | Resignation | Reason | To pursue other personal commitment. | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Degree | Electrical Engineering | University of Malaya | |
Working experience and occupation | Mr. Yen Yew Wing @ Yen Yew Ming graduated with a Degree in Electrical Engineering (Hons) from University of Malaya in 1978. He began his career as a Project Engineer in an engineering company in 1979 before joining Bintai Kindenko (M) Sdn Bhd in 1982. He took the opportunity to gain more knowledge during the Malaysia's Look East Policy", where he was actively involved in the design and electrical installation for some foreign investments. Throughout the years with Bintai Group, he has vast experiences in mechanical and electrical engineering works which enable him to contribute significantly to Bintai Group. He is the President of Kejuruteraan Bintai Kindenko Sdn Bhd, a wholly-owned subsidiary of the Company. |
Date of change | 16 Dec 2020 | Name | MR ONG PUAY KOON | Age | 77 | Gender | Male | Nationality | Malaysia | Designation | Vice Chairman | Directorate | Executive | Type of change | Resignation | Reason | To pursue other personal commitment. | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Diploma | Electrical Engineering | Singapore Polytechnic | | | 2 | Professional Qualification | Engineering | Institute of Incorporated Engineers, United Kingdom | |
Working experience and occupation | Mr. Ong Puay Koon graduated with a Diploma in Electrical Engineering from the Singapore Polytechnic in 1965. He is an Associate Member of the Institution of Incorporated Engineers, United Kingdom since 1978. Mr. Ong began his career as an engineer in charge of Project Management and Project Financing. His commitment towards his career has enabled him to be an experienced engineer in Electrical and Mechanical Engineering, Design and Construction works. His in-depth knowledge and experience has contributed significantly to the growth and expansion of the company where he managed to lead the business development team. In 1982, he together with the late Tuan Syed Ahmad Bin Abu Bakar and Kinden Corporation of Japan had formed Kejuruteraan Bintai Kindenko Sdn Bhd, a wholly-owned subsidiary of the Company. | Family relationship with any director and/or major shareholder of the listed issuer | Mr. Ong Puay Koon is the father of Mr. Ong Choon Lui, the Group Managing Director / Chief Executive Officer of the Company. | Any conflict of interests that he/she has with the listed issuer | None | Details of any interest in the securities of the listed issuer or its subsidiaries | Deemed interested in 61,517,184 ordinary shares held by Bintai Holdings (M) Sdn Bhd and Bin Tai Holdings Pte Ltd pursuant to Section 8(4) of the Companies Act 2016. |
Date of change | 16 Dec 2020 | Name | DATUK SHARIFAH KADNARIAH BINTI SYED AHMAD | Age | 49 | Gender | Female | Nationality | Malaysia | Designation | Director | Directorate | Executive | Type of change | Resignation | Reason | To pursue other personal commitment. | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Masters | Legal | LLM in Commercial and Corporate Law, University of London, United Kingdom | | | 2 | Degree | Legal | LLB Hons, Middlesex University London, United Kingdom | | | 3 | Diploma | Legal | PgDip BVC, University of West England, Bristol, United Kingdom | |
Working experience and occupation | Datuk Sharifah Kadnariah Binti Syed Ahmad graduated with a LLB Hons (upper second class) from Middlesex University London, United Kingdom. Then she pursued her studies and completed her law qualification, PgDip BVC from University of West England, Bristol in 2007 and was called to the Bar by the Honourable Inner Temple Society. In 2009, she completed her LLM in Commercial and Corporate Law from the University of London. She is a Member of the Malaysian Institute of Arbitrators and a Certified Enterprise Risk Manager (ERM) of the Institute of Enterprise Risk Practitioners. Datuk Sharifah was an experienced practising lawyer over a great number of years that covers litigation, commercial, employment and family law. Her experience in legal practise and ERM knowledge enable her to contribute resourcefully to the Company. | Family relationship with any director and/or major shareholder of the listed issuer | None | Any conflict of interests that he/she has with the listed issuer | None | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct shareholding of 60,000 ordinary shares in Bintai Kinden Corporation Berhad ("Bintai"). |
| BINTAI KINDEN CORPORATION BERHAD |
Particulars of substantial Securities HolderName | BINTAI HOLDINGS (M) SDN BHD | Address | No. 8A, Jalan Vivekananda,Brickfields
Kuala Lumpur
50470 Wilayah Persekutuan
Malaysia. | Company No. | 199301007820 (262557-W) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 16 Dec 2020 | 28,500,000 | Disposed | Direct Interest | Name of registered holder | Bintai Holdings (M) Sdn Bhd | Address of registered holder | No. 8A, Jalan Vivekananda, Brickfields, 50470 Kuala Lumpur | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal in the open market | Nature of interest | Direct Interest | Direct (units) | 31,687,184 | Direct (%) | 9.05 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 31,687,184 | Date of notice | 18 Dec 2020 | Date notice received by Listed Issuer | 18 Dec 2020 |
Notice of Person Ceasing (Section 139 of CA 2016)| BINTAI KINDEN CORPORATION BERHAD |
Particulars of Substantial Securities HolderName | NUSANKOTA DEVELOPMENT SDN BHD | Address | D12, Tingkat 1, Plaza Pekeliling, No. 2, Jalan Tun Razak
Kuala Lumpur
50400 Wilayah Persekutuan
Malaysia. | Company No. | 939201-H | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary shares | Name of registered holder | Nusankota Development Sdn Bhd | Address of registered holder | D12, Tingkat 1, Plaza Pekeliling, No. 2, Jalan Tun Razak,50400 Kuala Lumpur | Date of cessation | 16 Dec 2020 |
No of securities disposed | 50,025,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal in the open market | Nature of interest | Direct Interest |  | Date of notice | 18 Dec 2020 | Date notice received by Listed Issuer | 18 Dec 2020 |
| BINTAI KINDEN CORPORATION BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Others | Details of corporate proposal | Proposed settlement of the outstanding debt owing by Optimal Property Management Sdn Bhd, a wholly-owned subsidiary of Bintai Kinden Corporation Berhad of RM23,397,091.37 to Handal Jayabina Sdn Bhd | No. of shares issued under this corporate proposal | 31,800,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.6450 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 381,891,740 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 110,657,887.000 | Listing Date | 07 Jan 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 19-8-2021 08:56 AM
|
显示全部楼层
本帖最后由 icy97 于 18-10-2021 08:36 AM 编辑
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)| BINTAI KINDEN CORPORATION BERHAD |
Particulars of Substantial Securities HolderName | HANDAL JAYABINA SDN BHD | Address | 128-1, Jalan Rahmat 1, Taman Malim Jaya
Melaka
75250 Melaka
Malaysia. | Company No. | 201201022965 (1007457-P) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Handal Jayabina Sdn Bhd | Address of registered holder | 128-1, Jalan Rahmat 1 Taman Malim Jaya75250 Melaka |
| Date interest acquired & no of securities acquired | Date interest acquired | 06 Jan 2021 | No of securities | 31,800,000 | Circumstances by reason of which Securities Holder has interest | Part Settlement of outstanding debts owing by Optimal Property Management Sdn Bhd, a wholly owned subsidiary of Bintai Kinden Corporation Berhad ("the Company") via the issuance and allotment of 31,800,000 ordinary shares in the Company. | Nature of interest | Direct Interest | | | Total no of securities after change | Direct (units) | 31,800,000 | Direct (%) | 8.327 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 07 Jan 2021 | Date notice received by Listed Issuer | 07 Jan 2021 |
Type | Announcement | Subject | OTHERS | Description | Bintai Kinden Corporation Berhad (BKCB or Company)Distribution Agreement between Bintai Healthcare Sdn Bhd and SLAB Asia Co., Ltd. | For details of this announcement, please refer to the attachment.
This announcement is dated 8 January 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119621
Notice of Person Ceasing (Section 139 of CA 2016)| BINTAI KINDEN CORPORATION BERHAD |
Particulars of Substantial Securities HolderName | HANDAL JAYABINA SDN BHD | Address | 128-1, Jalan Rahmat 1, Taman Malim Jaya
Melaka
75250 Melaka
Malaysia. | Company No. | 201201022965 (1007457-P) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | Handal Jayabina Sdn Bhd | Address of registered holder | 128-1, Jalan Rahmat 1Taman Malim Jaya75250 Melaka | Date of cessation | 07 Jan 2021 |
No of securities disposed | 15,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal in the open market | Nature of interest | Direct Interest | | Date of notice | 11 Jan 2021 | Date notice received by Listed Issuer | 11 Jan 2021 |
| BINTAI KINDEN CORPORATION BERHAD |
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-12012021-00001 | Subject | Distribution Agreement between Bintai Healthcare Sdn Bhd (BHSB) and SLAB Asia Co. Ltd. | Description | Bintai Kinden Corporation Berhad ("BKCB" or "Company")- Distribution Agreement between Bintai Healthcare Sdn Bhd (BHSB) and SLAB Asia Co. Ltd. | Query Letter Contents | We refer to BINTAI’s announcement dated 8 January 2021 in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:
1) The operational impact of the Distribution Agreement on Bintai Group. 2) Whether BHSB possesses the required expertise, knowhow and resources to act as an exclusive distributor. 3) The risks in relation to the Distribution Agreement that BHSB may be exposed to and what are the processes and procedures put in place to mitigate the risks. 4) To elaborate the manner in which BHSB intends to market and distribute the Products in South East Asian countries. 5) Whether the Distribution Agreement and distribution of the Products require approval from the relevant authorities in Malaysia and the respective South East Asian countries, together with the name of the relevant authorities and status of approval. | For details of this announcment, please refer to the attachment.
This announcement is dated 13 January 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3120814
Type | Announcement | Subject | OTHERS | Description | Bintai Kinden Corporation Berhad (BKCB or Company)- Amended Announcement on the Distribution Agreements between Bintai Healthcare Sdn Bhd and SLAB Asia Co., Ltd. | For details of this announcement, please refer to the attachment.
This announcement is dated 4 February 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3126593
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | BINTAI KINDEN CORPORATION BERHAD ("BINTAI" OR THE "COMPANY")(I) PROPOSED DIVERSIFICATION; AND(II) PROPOSED PRIVATE PLACEMENT(COLLECTIVELY, THE "PROPOSALS") | On behalf of the Board of Directors of Bintai, M&A Securities Sdn Bhd wishes to announce that the Company intends to undertake the following proposals:
(a) proposed diversification of Bintai’s existing business to include the property development and management business segment (“Proposed Diversification”); and
(b) proposed private placement of up to 114,567,600 new ordinary shares in Bintai, representing approximately 30% of the existing issued ordinary shares in Bintai, to independent investors to be identified later (“Proposed Private Placement”).
(collectively, the “Proposals”)
Kindly refer to the attached announcement for further details of the said Proposals.
This announcement is dated 21 January 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3123169
Type | Announcement | Subject | OTHERS | Description | BINTAI KINDEN CORPORATION BERHAD ("BINTAI" OR "THE COMPANY")- BUSINESS COLLABORATION AGREEMENT BETWEEN BINTAI AND INTERNATIONAL EQUITIES CORPORATION LIMITED | For details of this announcement, please refer to the attcahment.
This announcement is dated 25 January 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3123806
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-10-2021 08:24 AM
|
显示全部楼层
| BINTAI KINDEN CORPORATION BERHAD |
Date of change | 01 Oct 2021 | Name | ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI | Age | 22 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Executive Director | New Position | Deputy Chief Executive Officer | Directorate | Executive |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Degree | Finance Investment and Risk | London Institute of Banking and Finance, United Kingdom | |
Working experience and occupation | Encik Noor Azri Bin Dato' Sri Noor Azerai graduated with an Honours Degree in Finance, Investment and Risk from London Institute of Banking and Finance, United Kingdom in 2021. Prior to this, in year 2018, he has gained some experience in Corporate Finance and Investment in Equity & Commodity Derivatives during his internship with M&A Securities Sdn Bhd and Maybank Investment Bank Berhad respectively, involving Initial Public Offering (IPO) exercise as well as managing portfolios of high value net worth individuals. He also founded a UK based company involved in investment in private companies in the United Kingdom and Europe.Currently, he also sits on the Board of several subsidiary companies of Bintai Group as well as a few other private limited companies in Malaysia and United Kingdom.Save as disclosed, he does not have any directorship in other public companies. | Family relationship with any director and/or major shareholder of the listed issuer | Nil | Any conflict of interests that he/she has with the listed issuer | Nil | Details of any interest in the securities of the listed issuer or its subsidiaries | As at todate, he has direct interest of 8,918,200 ordinary shares, representing 2.335% of the total issued share capital of the Company of 381,891,740 ordinary shares. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-10-2021 07:17 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 9-1-2022 07:43 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2021 | 30 Sep 2020 | 30 Sep 2021 | 30 Sep 2020 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 17,142 | 12,278 | 29,406 | 25,967 | | 2 | Profit/(loss) before tax | 244 | -2,999 | 1,499 | -4,462 | | 3 | Profit/(loss) for the period | 244 | -2,999 | 1,499 | -4,462 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 511 | -2,849 | 2,018 | -4,158 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.13 | -0.90 | 0.53 | -1.31 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3000 | 0.3000
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 22-1-2022 08:45 AM
|
显示全部楼层
| BINTAI KINDEN CORPORATION BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | PRIVATE PLACEMENT OF UP TO 30% OF THE TOTAL ISSUED SHARES IN BINTAI ("PRIVATE PLACEMENT") | No. of shares issued under this corporate proposal | 114,567,500 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.3000 | Par Value($$) (if applicable) | Malaysian Ringgit (MYR) 0.000 | | Latest issued share capital after the above corporate proposal in the following | Units | 496,459,240 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 145,028,137.000 | Listing Date | 30 Nov 2021 |
Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Acquisitions | Details of corporate proposal | PROPOSED ACQUISITION OF THE ENTIRE EQUITY INTEREST IN JOHNSON MEDICAL INTERNATIONAL SDN BHD FOR A TOTAL PURCHASE CONSIDERATION OF RM50,000,000 TO BE SATISFIED VIA A COMBINATION OF CASH PAYMENT OF RM26,000,000 AND THE REMAINING PURCHASE CONSIDERATION OF RM24,000,000 TO BE SATISFIED VIA THE ISSUANCE AND ALLOTMENT OF 58,536,600 NEW ORDINARY SHARES IN BINTAI (BINTAI SHARE(S) OR SHARE(S)) AT THE ISSUE PRICE OF RM0.41 PER SHARE ("PROPOSED ACQUISITION") | No. of shares issued under this corporate proposal | 58,536,600 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.4100 | Par Value($$) (if applicable) | Malaysian Ringgit (MYR) 0.000 | | Latest issued share capital after the above corporate proposal in the following | Units | 554,995,840 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 169,028,137.000 | Listing Date | 30 Nov 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 27-2-2022 12:15 AM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
2418 
102
